News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current SNG market cap is 10.16M. The company's latest EPS is GBP -0.0876 and P/E is -0.58.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 105k | 0 | 0 | 0 | 0 |
| Operating Income | -4.13M | -4.82M | -17.74M | -57.87M | -20.3M |
| Net Income | -3.3M | -3.89M | -13.92M | -48.66M | -17.65M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 6.8M | 4.07M | 88.55M | 44.64M | 23.53M |
| Total Liabilities | 777k | 1.82M | 3.41M | 7.64M | 3.25M |
| Total Equity | 6.03M | 2.25M | 85.14M | 37M | 20.28M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -3.82M | -2.9M | -23.82M | -41.02M | -14.29M |
| Investing | 1.59M | 66k | -45k | -21k | -3.62M |
| Financing | 2.67M | N/A | 96.39M | -112k | 1,000 |
| Market Cap | 10.16M |
| Price to Earnings Ratio | -0.58 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.64 |
| Price to Book Ratio | 0.5 |
| Dividend Yield | - |
| Shares Outstanding | 201.35M |
| Average Volume (1 week) | 106.25k |
| Average Volume (1 Month) | 414.57k |
| 52 Week Change | -24.14% |
| 52 Week High | 10.62 |
| 52 Week Low | 3.65 |
| Spread (Intraday) | 0.77 (14.05%) |
| Company Name | Synairgen Plc |
| Address |
mailpoint 810, level f southampton SO16 6YD |
| Website | https://www.synairgen.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
